Showing results (31-40 of 91) with videos related to
Sort By:
Pageof 10
Mabs|November 27, 2019
In vivo safety profile of a CSPG4-directed IgE antibody in an immunocompetent rat modelIwan P Williams, Silvia Crescioli, Heng Sheng Sow, et al.Scientific Reports|July 31, 2014
A tool kit for rapid cloning and expression of recombinant antibodiesTihomir S Dodev, Panagiotis Karagiannis, Amy E Gilbert, et al.British Journal of Clinical Pharmacology|April 27, 2025
Implementation of mass pharmacogenetic testing: Dihydropyrimidine dehydrogenase testing prior to fluoropyrimidine treatment for patientsNisha Shaunak, Jessica Keen, Anna Kim, et al.Clinical Colorectal Cancer|September 4, 2003
Impact of 5-fluorouracil rechallenge on subsequent response and survival in advanced colorectal cancer: pooled analysis from three consecutive randomized controlled trialsCheng Yeoh, Ian Chau, David Cunningham, et al.Oncotarget|June 2, 2016
Targeting folate receptor alpha for cancer treatmentAnthony Cheung, Heather J Bax, Debra H Josephs, et al.Future Oncology (London, England)|December 5, 2019
Tumor burden and liver function in HCC patient selection for selective internal radiation therapy: SARAH post-hoc studyDaniel H Palmer, Neil S Hawkins, Valérie Vilgrain, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2004
Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer--pooled analysis from three multicenter, randomized, controlled trials using individual patient dataIan Chau, Andy R Norman, David Cunningham, et al.Journal of Cancer Research and Clinical Oncology|July 28, 2020
Systematic review and network meta-analyses of third-line treatments for metastatic colorectal cancerThomas Walter, Neil S Hawkins, Richard F Pollock, et al.Cancer Immunology, Immunotherapy : CII|December 6, 2011
Recombinant IgE antibodies for passive immunotherapy of solid tumours: from concept towards clinical applicationSophia N Karagiannis, Debra H Josephs, Panagiotis Karagiannis, et al.Ebiomedicine|April 9, 2019
IgE re-programs alternatively-activated human macrophages towards pro-inflammatory anti-tumoural statesGiulia Pellizzari, Coran Hoskin, Silvia Crescioli, et al.Pageof 10